Personalized vaccine targets key driver mutations and induces antitumor immunity in fully resected high-risk clear cell renal cell carcinoma.

In a clinical trial, patients treated with a kidney cancer vaccine remained cancer-free after a median of nearly three years.

A new personalized cancer vaccine has shown encouraging results in preventing the return of kidney cancer after surgery.

The new vaccine is "personalized," meaning it is designed to train the patient's immune system to recognize and eliminate any remaining cells of that person's cancer.

Get real-time updates on health from celebrity fitness secrets and weight loss breakthroughs to nutrition advice, get your ...

Scientists are encouraged by findings that jab can eliminate tumour in patients with stage three or four kidney cancer ...

A groundbreaking study has delivered "exciting" findings, indicating that a new cancer vaccine could be on the verge of ...

A potential new cancer vaccine could be on the horizon as a study has yielded “exciting” results. Scientists have revealed ...

Researchers have found that a small vaccine, currently in its early trial phase, can enhance immune system response to fight ...

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...